ALT vs AME · rev $20.0K vs P/E 30, rev $7.40B
Altimmune Inc (ALT) versus Ametek Inc (AME) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
Latest reported AME revenue for 2025-12-31 was $7.40B. Net income was $1.48B. Revenue was up 6.6% from 2024-12-31 to 2025-12-31. AME currently screens at market cap $42.11B and trailing P/E 29.9.
ALT currently screens at market cap $527.0M. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Not investment advice. Open the ALT and AME stock pages for the full models.
Not investment advice.